See below: Patients with cutaneous and indolent systemic mastocytosis have a favorable prognosis, over 95% of them life expectancy is not reduced. In >50% of the cases of cutaneous mastocytosis in children, there is remission by the time the patient reaches adolescence. In adults it is generally chronic; only in a small proportion of patients with indolent systemic mastocytosis does it tend to regress.
Answered 3/13/2019
5.6k views
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question